Holen Sie sich die Stockscreener-App
17.49
0.81%
0.14
Handel nachbörslich:
17.49
Schlusskurs vom Vortag:
$17.35
Offen:
$16.9
24-Stunden-Volumen:
1.87M
Relative Volume:
1.26
Marktkapitalisierung:
$3.05B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-382.71M
KGV:
-6.6756
EPS:
-2.62
Netto-Cashflow:
$-325.64M
1W Leistung:
+8.57%
1M Leistung:
+8.23%
6M Leistung:
+13.35%
1J Leistung:
-40.59%
1-Tages-Spanne:
$16.77
$17.88
1-Wochen-Bereich:
$16.04
$17.88
52-Wochen-Spanne:
$12.72
$32.10
Immunovant Inc Stock (IMVT) Company Profile
Firmenname
Immunovant Inc
Sektor
Branche
Telefon
917-580-3099
Adresse
320 WEST 37TH STREET, NEW YORK, NY
Vergleichen Sie IMVT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMVT
Immunovant Inc
|
17.49 | 2.97B | 0 | -382.71M | -325.64M | -2.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immunovant Inc Stock (IMVT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-03-03 | Eingeleitet | Jefferies | Hold |
| 2025-01-03 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-10-09 | Bestätigt | Oppenheimer | Outperform |
| 2024-03-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-03-13 | Eingeleitet | Goldman | Buy |
| 2024-02-20 | Eingeleitet | JP Morgan | Overweight |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-13 | Hochstufung | UBS | Neutral → Buy |
| 2023-09-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-01 | Eingeleitet | BofA Securities | Buy |
| 2023-04-25 | Eingeleitet | Citigroup | Buy |
| 2023-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2023-03-30 | Eingeleitet | Stifel | Buy |
| 2023-02-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-02-13 | Hochstufung | Guggenheim | Neutral → Buy |
| 2023-01-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-09-26 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-08-03 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-08-02 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-06-01 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-06-01 | Herabstufung | Stifel | Buy → Hold |
| 2020-10-28 | Eingeleitet | UBS | Buy |
| 2020-10-12 | Eingeleitet | Guggenheim | Buy |
| 2020-10-08 | Eingeleitet | Stifel | Buy |
| 2020-10-02 | Eingeleitet | Credit Suisse | Outperform |
| 2020-08-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-25 | Eingeleitet | Raymond James | Outperform |
| 2020-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-02-24 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Immunovant Inc Aktie (IMVT) Neueste Nachrichten
Truist Securities initiates Immunovant stock with Hold rating, $16 target - Investing.com
Visualizing Immunovant Inc. stock with heatmapsBond Market & Weekly Chart Analysis and Trade Guides - newser.com
Why Immunovant Inc. stock is popular among millennials2025 Market WrapUp & Daily Price Action Insights - newser.com
Key resistance and support levels for Immunovant Inc.July 2025 Rallies & Stepwise Trade Signal Implementation - newser.com
Will Immunovant Inc. stock outperform value stocksGold Moves & Safe Capital Investment Plans - newser.com
Trend analysis for Immunovant Inc. this weekQuarterly Earnings Report & Risk Managed Investment Strategies - newser.com
Statistical indicators supporting Immunovant Inc.’s strengthJuly 2025 Movers & Expert Approved Momentum Ideas - newser.com
How analysts rate Immunovant Inc. stock todayJuly 2025 Review & Free Technical Pattern Based Buy Signals - newser.com
Analyzing drawdowns of Immunovant Inc. with statistical toolsPortfolio Growth Summary & Stock Timing and Entry Methods - newser.com
Reversal indicators forming on Immunovant Inc. stockJuly 2025 Action & High Accuracy Swing Entry Alerts - newser.com
How hedge fund analytics apply to Immunovant Inc. stockDollar Strength & Short-Term Trading Alerts - newser.com
Immunovant (NASDAQ:IMVT) Insider Michael Geffner Sells 1,272 Shares - MarketBeat
Immunovant (NASDAQ:IMVT) Shares Up 7.2%Here's What Happened - MarketBeat
Immunovant’s chief technology officer sells $25,835 in stock By Investing.com - Investing.com South Africa
Will breakout in Immunovant Inc. lead to full recovery2025 Technical Patterns & AI Driven Price Predictions - newser.com
Immunovant Inc. stock momentum explainedMarket Weekly Review & Daily Growth Stock Investment Tips - newser.com
Smart tools for monitoring Immunovant Inc.’s price action2025 Earnings Impact & Weekly Top Gainers Trade List - newser.com
JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN
Published on: 2025-10-09 06:28:21 - newser.com
Using Ichimoku Cloud for Immunovant Inc. technicalsMarket Activity Summary & Real-Time Volume Analysis Alerts - newser.com
Is Immunovant Inc. forming a bottoming baseJuly 2025 Decliners & Community Trade Idea Sharing Platform - newser.com
Why Immunovant Inc. stock remains undervalued2025 Bull vs Bear & Stock Market Timing Techniques - newser.com
Platinum Investment Management Ltd. Grows Position in Immunovant, Inc. $IMVT - MarketBeat
Where is Immunovant (IMVT) Heading According to Analysts? - MSN
Immunovant (NASDAQ:IMVT) Given New $33.00 Price Target at JPMorgan Chase & Co. - MarketBeat
12 Best Strong Buy Stocks to Invest in According to Wall Street - Insider Monkey
Immunovant (IMVT) Up 7.8% Since Last Earnings Report: Can It Continue? - MSN
Is Asahi India Glass Limited One of the Top Picks for Growth Investors in YEARPrice Action Analysis & Free Phenomenal Trading Returns - earlytimes.in
What analysts say about Immunovant Inc stockFinancial Sector Performance & Free Proven Portfolio Growth Strategies - earlytimes.in
Banque Pictet & Cie SA Has $2.02 Million Stock Holdings in Immunovant, Inc. $IMVT - MarketBeat
Insider Sale: President & Immunovant CEO of $ROIV Sells 683,818 Shares - Quiver Quantitative
Immunovant, Inc. (NASDAQ:IMVT) Receives $33.60 Consensus PT from Analysts - MarketBeat
Aug Spikes: Is Immunovant Inc. a play on infrastructure spendingEarnings Recap Summary & Precise Buy Zone Tips - خودرو بانک
FOMO Trade: What are Immunovant Incs earnings expectations2025 Bull vs Bear & Fast Gaining Stock Strategy Reports - khodrobank.com
Finanzdaten der Immunovant Inc-Aktie (IMVT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immunovant Inc-Aktie (IMVT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Stout Jay S | Chief Technology Officer |
Oct 08 '25 |
Sale |
16.30 |
1,585 |
25,836 |
203,334 |
| Stout Jay S | Chief Technology Officer |
Jul 23 '25 |
Sale |
18.15 |
2,805 |
50,911 |
204,919 |
| Geffner Michael | Chief Medical Officer |
Jul 23 '25 |
Sale |
18.15 |
2,385 |
43,288 |
221,825 |
| Geffner Michael | Chief Medical Officer |
Jul 09 '25 |
Sale |
17.24 |
1,160 |
19,998 |
224,210 |
| Stout Jay S | Chief Technology Officer |
Jul 09 '25 |
Sale |
17.24 |
1,519 |
26,188 |
207,724 |
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):